Abstract
Drug-induced gingival overgrowth is medication-related gingival overgrowth commonly associated with certain systemic medications. Gingival overgrowth is a common adverse effect of phenytoin therapy. The condition is more frequently seen in children as compared to adults, affects both genders equally, and may vary from mild to severe. It may be associated with difficulty in mastication, delayed eruption of teeth, tissue trauma, and secondary inflammation. It can be managed by both surgical and nonsurgical therapies. A case of dental management of phenytoin-induced gingival enlargement in a 7-year-old girl is presented with a brief literature review.
Reference11 articles.
1. The treatment of epilepsy with sodium diphenylhydantoinate;Kimball;JAMA,1939
2. Kumar R, Singh RK, Verma N, et al. Phenytoin-induced severe gingival overgrowth in a child. BMJ Case Rep. 2014;2014: bcr2014204046.
3. Neville BW, Damm DD, Allen CM, et al. Abnormalities of teeth. In: Oral and maxillofacial pathology. 1st South Asia Edition. Elsevier 2015;148-151.
4. Chacko LN, Abraham S. Phenytoin-induced gingival enlargement. BMJ Case Rep. 2014;2014: bcr2014204670.
5. Jindal G, Pandey RK, Kumar D. Generalised stunting of roots in an epileptic child: is long term phenytoin therapy the cause? BMJ Case Rep. 2012;2012:bcr0320126042.